Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Reeder

Showing results (391-400 of 465) with videos related to

Pageof 47
Sort By:
Leukemia|August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myelomaT E Witzig, K M Laumann, M Q Lacy, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2018
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective StudyTania Jain, Heidi E Kosiorek, Shu T Kung, et al.
Science (New York, N.Y.)|April 27, 2013
Topology of feather melanocyte progenitor niche allows complex pigment patterns to emergeS J Lin, J Foley, T X Jiang, et al.
European Radiology|December 15, 2018
Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobesSoudabeh Fazeli Dehkordy, Kathryn J Fowler, Adrija Mamidipalli, et al.
Leukemia & Lymphoma|July 25, 2022
Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United StatesKaran L Chohan, Jithma P Abeykoon, Stephen M Ansell, et al.
Leukemia|July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I studyG S Nowakowski, B LaPlant, T M Habermann, et al.
Blood|September 29, 2018
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphomaHan W Tun, Patrick B Johnston, Lisa M DeAngelis, et al.
British Journal of Haematology|November 19, 2013
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemiaAneel Paulus, Kasyapa Chitta, Sharoon Akhtar, et al.
Radiology|October 4, 2022
Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRIDiego Hernando, Ruiyang Zhao, Qing Yuan, et al.
European Radiology|July 16, 2021
Abdominal fellowship-trained versus generalist radiologist accuracy when interpreting MR and CT for the diagnosis of appendicitisRebecca L Bracken, John B Harringa, B Keegan Markhardt, et al.
Pageof 47

Showing results (391-400 of 465) with videos related to

Sort By:
Pageof 47
Leukemia|August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myelomaT E Witzig, K M Laumann, M Q Lacy, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2018
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective StudyTania Jain, Heidi E Kosiorek, Shu T Kung, et al.
Science (New York, N.Y.)|April 27, 2013
Topology of feather melanocyte progenitor niche allows complex pigment patterns to emergeS J Lin, J Foley, T X Jiang, et al.
European Radiology|December 15, 2018
Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobesSoudabeh Fazeli Dehkordy, Kathryn J Fowler, Adrija Mamidipalli, et al.
Leukemia & Lymphoma|July 25, 2022
Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United StatesKaran L Chohan, Jithma P Abeykoon, Stephen M Ansell, et al.
Leukemia|July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I studyG S Nowakowski, B LaPlant, T M Habermann, et al.
Blood|September 29, 2018
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphomaHan W Tun, Patrick B Johnston, Lisa M DeAngelis, et al.
British Journal of Haematology|November 19, 2013
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemiaAneel Paulus, Kasyapa Chitta, Sharoon Akhtar, et al.
Radiology|October 4, 2022
Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRIDiego Hernando, Ruiyang Zhao, Qing Yuan, et al.
European Radiology|July 16, 2021
Abdominal fellowship-trained versus generalist radiologist accuracy when interpreting MR and CT for the diagnosis of appendicitisRebecca L Bracken, John B Harringa, B Keegan Markhardt, et al.
Pageof 47